ArticleEpilepsia2026
Unilateral ultra long-term subcutaneous EEG monitoring in drug-refractory idiopathic generalized epilepsy.
Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Subdermal Insertable Sensors for Health Monitoring: Applications, Challenges, and Emerging Technologies.Annals of biomedical engineering · 2026Review
- Unilateral ultra long-term subcutaneous EEG monitoring in drug-refractory idiopathic generalized epilepsy.Epilepsia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveSeizure self-reporting is known to be unreliable, particularly with non-convulsive seizures. There is increasing interest in long-term monitoring systems to detect and count seizures, including the use of the minimally-invasive CE-marked subcutaneous unilateral electroencephalography (EEG) recording system, which has been shown to accurately detect ipsilateral focal seizures.
methodsWe implanted the subcutaneous EEG system in nine patients with refractory idiopathic generalized epilepsy (IGE), following initial characterization of their inter-ictal and ictal EEG abnormalities, with in-patient video-EEG monitoring as gold standard comparison. We compared the in-patient video-EEG findings to the abnormalities detected on the long-term subcutaneous system in seven of the nine patients. We compared EEG signal characteristics for convulsive seizures, and for spike and wave discharges of duration of <3 s, between 3 to 10 s, and greater than 10 s.
resultsThree generalized convulsive seizures were recorded in total during video-EEG monitoring, and all were easily detected by the long-term subcutaneous EEG system. Ninety percent of significant spike and wave discharges lasting >3 s were identified using the subcutaneous EEG device. There were minimal adverse effects from use of the device; the patients were satisfied that the device was easy to use and were likely to recommend the use of the device to other patients with epilepsy, as measured by Likert scales. The device implantation was judged to be easy by our epilepsy neurosurgeons. SIGNIFICANCE: This study demonstrates that ultra long-term monitoring with unilateral subcutaneous EEG can reliably detect all convulsive and most non-convulsive generalized seizures in patients with refractory IGE. The device is well tolerated and easy to insert, and it can be used as a useful adjunctive seizure monitoring system in select patients. Furthermore, it may guide therapy to optimize seizure control, and it may confer cost savings by avoiding the need for in-patient video monitoring in appropriate patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.